Long-term prospects and implications of biotechnology for Europe: Strategic challenge and response Online publication date: Wed, 27-May-2009
by Mark F. Cantley
International Journal of Technology Management (IJTM), Vol. 1, No. 1/2, 1986
Abstract: To gain the full benefits offered by recent rapid developments in biotechnology, Europe must deploy her technical resources to maximum effectiveness. Inadequate strategic management – rather than research or limitations on technological forecasting – represents the major obstacle preventing Europe from taking advantage of the opportunities biotechnology presents. European governments have been slow to recognise the industrial potential of biotechnological innovation. Recent initiatives of the Commission of the European Communities in establishing the FAST programme and the creation of the Concertation Unit for Biotechnology in Europe (CUBE) demonstrate a desire on the part of the Community to bring greater coherence and strategic rationality into its R&D policy. But strategic management continues to be hampered by the communication gap that exists between science and politics – a gap that is in danger of widening as technological change outpaces the capacity of political decision-making machinery to adapt.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology Management (IJTM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook